advertisement

WGA Rescources

Wu P 10

Showing records 1 to 10 | Display all abstracts from Wu P

107637 Characteristics of Mitomycin C-Loaded Peptide Hydrogel and Antiscarring Effects in Rat Ocular Injury Model
Wu P
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 139-147
108476 Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation
Bai X; Ye D
Investigative Ophthalmology and Visual Science 2023; 64: 31
107637 Characteristics of Mitomycin C-Loaded Peptide Hydrogel and Antiscarring Effects in Rat Ocular Injury Model
Wang Z
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 139-147
108476 Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation
Shi Y
Investigative Ophthalmology and Visual Science 2023; 64: 31
107637 Characteristics of Mitomycin C-Loaded Peptide Hydrogel and Antiscarring Effects in Rat Ocular Injury Model
Liang L
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 139-147
108476 Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation
Fan M
Investigative Ophthalmology and Visual Science 2023; 64: 31
107637 Characteristics of Mitomycin C-Loaded Peptide Hydrogel and Antiscarring Effects in Rat Ocular Injury Model
Chen B
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 139-147
108476 Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation
Lu P
Investigative Ophthalmology and Visual Science 2023; 64: 31
107637 Characteristics of Mitomycin C-Loaded Peptide Hydrogel and Antiscarring Effects in Rat Ocular Injury Model
Xu N
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 139-147
108476 Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation
Feng Y; Hu C; Liao J; Cui K; Tang X; Wu P; Xu F; Xu Y; Huang J
Investigative Ophthalmology and Visual Science 2023; 64: 31

Issue 23-4

Change Issue


advertisement

Oculus